(Q86632515)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605289%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

title

When clinical trials fail to address treatment gaps: the failure of niacin-laropiprant to reduce cardiovascular events (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605289%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

author name string

Robert S Rosenson

series ordinal

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605289%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Antonio M Gotto

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605289%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

1 June 2013

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605289%20AND%20SRC:MED&resulttype=core&format=json

Current Atherosclerosis Reports

29 February 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605289%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605289%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605289%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

page(s)

332

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23605289%20AND%20SRC:MED&resulttype=core&format=json

Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol (ARBITER) 2: a double-blind, placebo-controlled study of extended-release niacin on atherosclerosis progression in secondary prevention patients treated with sta

29 February 2020

cites work

1 reference

12 December 2020

Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy

1 reference

12 December 2020

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report

1 reference

12 December 2020

Regression of coronary artery disease as a result of intensive lipid-lowering therapy in men with high levels of apolipoprotein B

1 reference

12 December 2020

Prevention of Cardiovascular Events and Death with Pravastatin in Patients with Coronary Heart Disease and a Broad Range of Initial Cholesterol Levels

1 reference

12 December 2020

Extended-release niacin or ezetimibe and carotid intima-media thickness.

1 reference

12 December 2020

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

12 December 2020

Clinical trials of HDL cholesterol-raising therapy: what have we learned about the HDL hypothesis from AIM-HIGH?

1 reference

12 December 2020

Clofibrate and niacin in coronary heart disease

1 reference

12 December 2020

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

12 December 2020

Fifteen year mortality in Coronary Drug Project patients: long-term benefit with niacin

1 reference

12 December 2020

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

12 December 2020

Nicotinic acid: the broad-spectrum lipid drug. A 50th anniversary review

1 reference

12 December 2020

Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines

1 reference

12 December 2020

Regression of coronary atherosclerosis during treatment of familial hypercholesterolemia with combined drug regimens.

1 reference

12 December 2020

The effect of 24 months of combination statin and extended-release niacin on carotid intima-media thickness: ARBITER 3

1 reference

12 December 2020